Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 19, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Overview of prostate-specific membrane antigen.

Sam S Chang

    Reviews in Urology
    |September 21, 2006
    PubMed
    Summary

    Prostate-specific membrane antigen (PSMA) is a key target for prostate cancer diagnostics and therapeutics. Research indicates PSMA may also serve as a valuable marker for other cancer types, expanding its clinical potential.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Durable Responses and Cystectomy Avoidance with IL-15 Receptor Agonist NAI plus BCG In BCG-Unresponsive NMIBC with Carcinoma In Situ +/- Papillary Disease.

    The Journal of urology·2026
    Same author

    Management of Xanthogranulomatous Pyelonephritis: A Review of Current Evidence and Treatment Strategies and a Proposed Clinical Management Algorithm.

    Urology·2026
    Same author

    Cost-Effectiveness of Immune Checkpoint Inhibitor Therapy plus BCG for High-Risk Non-Muscle-Invasive Bladder Cancer: Analyses of CREST, POTOMAC, and ALBAN.

    The Journal of urology·2026
    Same author

    Noninvasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Prospective Multisite Validation and Comparison with MRI.

    The Journal of urology·2026
    Same author

    Reply to Editorial Comment on "Longitudinal Trends in Urology In-service Examination Performance: 2016-2023".

    Urology·2026
    Same author

    Editorial Comment.

    The Journal of urology·2026

    Area of Science:

    • Oncology
    • Biomarker Discovery
    • Immunotherapy

    Background:

    • Prostate cancer diagnosis and treatment research is ongoing.
    • Prostate-specific membrane antigen (PSMA) is a transmembrane protein found in all prostatic tissues.
    • PSMA shows promise as a diagnostic and therapeutic target.

    Purpose of the Study:

    • To evaluate prostate-specific membrane antigen (PSMA) as a diagnostic and therapeutic marker.
    • To explore the potential of PSMA in targeting other malignancies beyond prostate cancer.

    Main Methods:

    • Utilized the anti-PSMA monoclonal antibody 7E11 in a radio-immunoconjugate form.
    • Leveraged the ProstaScint scan, an FDA-approved diagnostic tool, for PSMA targeting.

    Main Results:

    • PSMA is a validated target for prostate cancer diagnostics.
    • The anti-PSMA antibody 7E11 is integral to the ProstaScint scan.
    • Emerging evidence suggests PSMA's utility in other cancer types.

    Conclusions:

    • Prostate-specific membrane antigen (PSMA) remains a significant target in prostate cancer.
    • PSMA's role may extend to diagnosing and treating other cancers.
    • Further research into PSMA's broader applications is warranted.

    More Related Videos

    miRNA Expression Analyses in Prostate Cancer Clinical Tissues
    11:29

    miRNA Expression Analyses in Prostate Cancer Clinical Tissues

    Published on: September 8, 2015

    How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases
    13:18

    How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases

    Published on: September 20, 2016

    Related Experiment Videos

    Last Updated: Jul 19, 2026

    MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
    06:54

    MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

    Published on: September 3, 2013

    miRNA Expression Analyses in Prostate Cancer Clinical Tissues
    11:29

    miRNA Expression Analyses in Prostate Cancer Clinical Tissues

    Published on: September 8, 2015

    How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases
    13:18

    How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases

    Published on: September 20, 2016